First patient dosed in Phase III clinical trial for PET radiopharmaceutical Next stage clinical study also proceeding for SPECT radiopharmaceutical Both imaging agents aim to assist in the evaluation ...
GE Healthcare announced the US Food and Drug Administration (FDA) has approved DaTscan (Ioflupane I 123 Injection), a radiopharmaceutical agent intended for use with Single Photon Emission Computed ...
“A DaTScan is a nuclear imaging technology that uses a small amount of radioactive dye to look at density of dopamine-transporting proteins, which is reflective of how much dopamine is available in ...
Sarasota Memorial Hospital is using advanced imaging technology like DaTscan and PET scans to detect early signs of Alzheimer's and other dementias. These scans reveal brain function, unlike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results